Urology Times staff

Hospitals have virtually given up the search for solo physicians, as a symbol of America's tradition of independent medical practice fades from the scene, a new survey indicates.

Urinary incontinence may be a common problem among young women who have never been pregnant, according to a study in the Annals of Internal Medicine.

Extreme cuts to funding for medical imaging scans in the Medicare fee schedule proposed rule for 2013 are unnecessary, unfounded, and undermine care for the most sick or injure seniors, according to the American College of Radiology.

Physicians should discuss the benefits and risks of PSA testing with their asymptomatic male patients who have life expectancies of greater than 10 years, but the risks outweigh the benefits of men with shorter life expectancies, according to a new evidence-based provisional clinical opinion on prostate cancer screening issued by the American Society of Clinical Oncology.

Here are the take-home messages from the 2012 AUA annual meeting-cutting-edge research findings in 15 areas of clinical urology.

Urology drugs and devices in the pipeline from Janssen Research and Development, LLC; Auxilium Pharmaceuticals, Inc.; Tengion Inc.; Ampio Pharmaceuticals, Inc.; Tokai Pharmaceuticals, ImaginAb, Inc.; BZL Biologics, LLC; Agensys, Inc.; and Seattle Genetics, Inc.

The newest urology products and services from the Interstitial Cystitis Network, Wiley-Blackwell, and Medline Industries, Inc.

Drugs and devices in the pipeline from GTX Inc., Auxilium Pharmaceuticals, Inc., Tengion Inc., OncoGenex, and Tokai Pharmaceuticals, Inc.

New products and services from ProUroCare, Touch of Life Technologies, and MDxHealth.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes phase I-III overactive bladder trials and phase IV BPH trials that are currently recruiting participants. This list is current as of April 19, 2012. For more information, view the complete database at http://ClinicalTrials.gov.

The newest urology products and services from Olympus, Teleflex, Inc., Medline Industries, Inc., and Wiley-Blackwell.

Urologists agree that PSA screening will be the hot topic at the AUA annual meeting in Atlanta.

New urology products and services on the horizon.

Newly available urology products and services.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes phase II, III, and IV erectile dysfunction trials that are currently recruiting participants. This list is current as of March 17, 2010.

Erectile dysfunction is a strong predictor of death from all causes and of myocardial infarction, stroke, and heart failure in men with cardiovascular disease.

The National Association for Continence (NAFC) is calling for stricter health care standards for patients with pelvic floor dysfunction, including incontinence and prolapse in women.

Having trouble with a patient who refuses to pay his account balance? Learn about your options.

Educate your patients about urinary tract infection with a free, customizable handout.

In children with recurrent urinary tract infections, low-dose, continuous oral antibiotic therapy may help prevent future recurrences.

Using an extremely sensitive tool based on nanotechnology, researchers from Northwestern University, Chicago say they have detected previously undetectable levels of PSA in patients who have undergone radical prostatectomy.

The FDA has approved GlaxoSmithKline's pazopanib (Votrient) to treat patients with advanced renal cell carcinoma.

Information on new products from Accuray Inc., Covidien, Harvard Apparatus, EMG Productions, and KeyScan Inc.

Educate your patients about erectile dysfunction with a free, customizable handout.

Cardiometabolic disorders and urologic disease represent a "perfect storm" of ailments, according to Kevin T. McVary, MD, who discusses the urologist's role in management.

New urology products and services from Roche, Accuray Inc., American Medical Systems, Boston Scientific, Primal Pictures, Life-Tech, and Mpathy Medical.

Urology Times wants your stories.

Information on new products from Endo Pharmaceuticals, Envisionier Medical Technologies, biolitec, Inc., and Mission Pharmacal.

Dr. Jordan Dimitrakov discusses the use of memantine in chronic pelvic pain syndrome with Urology Times.

Dr. Williams and Dr. Nangia discuss the effects of cardiometabolic disorders in aging men.